STAT - Reporting from the frontiers of health and medicine

STAT - Reporting from the frontiers of health and medicine

January 2, 2020 Hyacinth Empinado/STAT W ASHINGTON — Politicians spent the better part of 2019 bickering over the best way to lower drug prices. But in the meantime, states, advocates — even the drug and insurance industries — were devising novel strategies for solving this perplexing challenge. 2020 will be the year many of those experimental ideas are tested. If they pan out, they’ll undoubtedly be models for other states or companies — and perhaps serve as inspiration for Washington, too. Below, STAT looks at three of the most interesting ideas. Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months! Log In | Learn More What is it? STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What's included? The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day Online intelligence briefings Frequent opportunities to engage with veteran beat reporters and industry experts Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more



Also in Industry News

CIHR Institute of Indigenous Peoples’ Health awards NEIHR grant to McGill University
CIHR Institute of Indigenous Peoples’ Health awards NEIHR grant to McGill University

0 Comments

CIHR Institute of Indigenous Peoples’ Health awards NEIHR grant to McGill University

Read More

Active support for stem cell research is key to alleviate incurable chronic diseases
Active support for stem cell research is key to alleviate incurable chronic diseases

0 Comments

Active support for stem cell research is key to alleviate incurable chronic diseases

Read More

A risk-based strategy towards COVID-19 will help optimize socioeconomic recovery
A risk-based strategy towards COVID-19 will help optimize socioeconomic recovery

0 Comments

A risk-based strategy towards COVID-19 will help optimize socioeconomic recovery

Read More